Peroxisome proliferator-activated receptor activity correlates with poor survival in patients resected for hepatocellular carcinoma.

Hans-Christian PommergaardJane Preuss HasselbyGro Linno WillemoeAdela RalbovskaAndreas Arendtsen RostvedAllan RasmussenNicolai Aagaard SchultzJens HillingsøPeter Nørgaard LarsenJan-Michael Kugler

Published in: Journal of hepato-biliary-pancreatic sciences (2020)

PPAR activity in a subset of tumor samples was associated with reduced overall survival indicating that PPAR may be a valuable prognostic biomarker.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed

insulin resistance
peritoneal dialysis
free survival

lymph node
type diabetes

adipose tissue
binding protein